Clinical Trial Update: The Comparison of XELOX and EOX in the First-line Treatment of Advanced Gastric Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing XELOX versus EOX as first-line therapy for advanced gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Eox
• XELOX (capecitabine + oxaliplatin)

Snippet

Sponsor: Fudan University | Conditions: Gastric Cancer | Phase 3 | Status: COMPLETED